المؤلفون: Shinji Tagami, Kanta Yanagida, Takashi S. Kodama, Mako Takami, Naoki Mizuta, Hiroshi Oyama, Kouhei Nishitomi, Yu-wen Chiu, Toru Okamoto, Takeshi Ikeuchi, Gaku Sakaguchi, Takashi Kudo, Yoshiharu Matsuura, Akio Fukumori, Masatoshi Takeda, Yasuo Ihara, Masayasu Okochi

المصدر: Cell Reports, Vol 21, Iss 1, Pp 259-273 (2017)

مصطلحات موضوعية: Alzheimer’s disease, γ-secretase inhibitors, clinical trials, semagacestat, Aβ hypothesis, γ-byproducts, RO4929097, MK-0752, avagacetat, anti-cancer drugs, Biology (General), QH301-705.5

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2211124717313074; https://doaj.org/toc/2211-1247

URL الوصول: https://doaj.org/article/e0c2b7842afc48ba9915c840c0c2dbd5